Summary

The management of rheumatoid arthritis (RA) requires effective strategies for optimizing drug selection and application. This article provides a review of the efficacy of novel compounds, the treat-to-target approach, and updated recommendations from the European League Against Rheumatism [Smolen JS et al. Ann Rheum Dis 2013]. Also discussed are considerations when initiating DMARDs during vaccinations.